Table 4.
Effect of Piperonal on Plasma lipid profiles in normal and experimental obese rats
| Groups | TC (mg/dl) | TG (mg/dl) | HDL (mg/dl) | LDL (mg/dl) | VLDL (mg/dl) | Phospholipids (mg/dl) | Free fatty acids (mg/dl) |
|---|---|---|---|---|---|---|---|
| ND control | 113.5±11.4 | 130.6±6.6 | 50.0±3.1 | 50.8±4.6 | 35.7±2.2 | 85.7±5.3 | 64.6±5.1 |
| HFD control | 311.1±20.2 a* | 259.5±8.5 a* | 26.6±2.9 a* | 130.8±5.9 a* | 81.7±4.1 a* | 147.9±5.7 a* | 116.1±4.6 a* |
| HFD + Orlistat5mg/kg b.wt | 142.6±9.8 b* | 136.6±11.1 b* | 46.8±3.4 b* | 55.8±5.5 b* | 41.6±4.4 b* | 100.3±5.2 b* | 71.2±4.3 b* |
| HFD+ Piperonal 20 mg/kg b.wt | 254.0±9.8 | 214.0±9.4 | 31.3±2.4 | 118.8±9.6 | 84.7±3.7 | 135.3±4.3 | 106.4±5.2 |
| HFD+ Piperonal 30 mg/kg b.wt | 211.0±8.2 | 188.5±10.4 | 38.7±2.1 | 94.7±5.8 | 74.1±4.6 | 113.2±10.6 | 88.6±7.6 |
| HFD+ Piperonal 40 mg/kg b.wt | 158.3±9.8 b* | 145.8±10.1 b* | 46.4±5.1 b* | 53.1±5.3 b* | 46.7±4.7 b* | 97.9±5.3 b* | 68.1±5.1 b* |
Values are statistically significant at * p < 0.05
aSignificantly different from normal control
bSignificantly different from HFD control